Pulmonary Erdheim-Chester Disease With BRAF-AGAP3 Fusion : Late-Onset Osteolytic Femoral Lesions Despite Long-Term Pulmonary Stabilization With Corticosteroid
Copyright © 2024, Nishino et al..
Erdheim-Chester disease (ECD) is a rare inflammatory myeloid neoplasm affecting multiple systems and organs. The patient is a 38-year-old male with ECD complicated with pulmonary and cutaneous manifestations but without bone lesions diagnosed in 2008. Initial treatment with oral and inhaled corticosteroids achieved persistent favorable disease remission. However, atypical late-onset bone lesions developed in the bilateral femur in 2021. Although BRAF-V600E mutation was negative in the lung specimen at diagnosis, the next-generation gene sequence using biopsied bone lesions revealed a rare BRAF-AGAP3 fusion, leading to the administration of trametinib. This is the first report describing ECD harboring BRAF-AGAP3 fusion successfully treated with trametinib. Our case presents a unique clinical course in which late-onset osteolytic bone lesions developed despite a long-term stabilization of pulmonary lesions with low-dose oral and inhaled corticosteroids.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Cureus - 16(2024), 3 vom: 28. März, Seite e55670 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nishino, Koichi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Braf-agap3 fusion |
|---|
| Anmerkungen: |
Date Revised 09.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.7759/cureus.55670 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370761197 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370761197 | ||
| 003 | DE-627 | ||
| 005 | 20240409233032.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240408s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7759/cureus.55670 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1370.xml |
| 035 | |a (DE-627)NLM370761197 | ||
| 035 | |a (NLM)38586706 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nishino, Koichi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary Erdheim-Chester Disease With BRAF-AGAP3 Fusion |b Late-Onset Osteolytic Femoral Lesions Despite Long-Term Pulmonary Stabilization With Corticosteroid |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024, Nishino et al. | ||
| 520 | |a Erdheim-Chester disease (ECD) is a rare inflammatory myeloid neoplasm affecting multiple systems and organs. The patient is a 38-year-old male with ECD complicated with pulmonary and cutaneous manifestations but without bone lesions diagnosed in 2008. Initial treatment with oral and inhaled corticosteroids achieved persistent favorable disease remission. However, atypical late-onset bone lesions developed in the bilateral femur in 2021. Although BRAF-V600E mutation was negative in the lung specimen at diagnosis, the next-generation gene sequence using biopsied bone lesions revealed a rare BRAF-AGAP3 fusion, leading to the administration of trametinib. This is the first report describing ECD harboring BRAF-AGAP3 fusion successfully treated with trametinib. Our case presents a unique clinical course in which late-onset osteolytic bone lesions developed despite a long-term stabilization of pulmonary lesions with low-dose oral and inhaled corticosteroids | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a braf-agap3 fusion | |
| 650 | 4 | |a erdheim-chester disease | |
| 650 | 4 | |a inhaled corticosteroids | |
| 650 | 4 | |a late-onset bone lesions | |
| 650 | 4 | |a trametinib | |
| 700 | 1 | |a Takagi, Tatsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Hayashi, Takuo |e verfasserin |4 aut | |
| 700 | 1 | |a Kunimine, Shinya |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuchihashi, Hitoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Shunsuke |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Kazuhisa |e verfasserin |4 aut | |
| 700 | 1 | |a Seyama, Kuniaki |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 16(2024), 3 vom: 28. März, Seite e55670 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:3 |g day:28 |g month:03 |g pages:e55670 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.55670 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 3 |b 28 |c 03 |h e55670 | ||